Published in Genetics on April 01, 1995
The genetics of caloric restriction in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1998) 7.21
The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell (2011) 6.05
Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev (1998) 5.77
Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics (2002) 5.52
Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics (1998) 5.37
Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci U S A (1995) 5.18
Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet (2007) 3.83
Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev (2001) 3.59
Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol (2010) 3.36
The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics (1995) 3.33
daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental cues and acts in the DAF-2 signaling pathway. Genes Dev (2003) 3.22
A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev (1999) 3.21
daf-12 encodes a nuclear receptor that regulates the dauer diapause and developmental age in C. elegans. Genes Dev (2000) 3.03
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79
A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation. Cell (2009) 2.61
A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling. Proc Natl Acad Sci U S A (2007) 2.50
Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae. Genetics (1999) 2.50
Quantitative trait loci for life span in Drosophila melanogaster: interactions with genetic background and larval density. Genetics (2000) 2.46
An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics (1998) 2.46
Genetic, behavioral and environmental determinants of male longevity in Caenorhabditis elegans. Genetics (2000) 2.41
A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics (1996) 2.40
Transcriptional profiling of MnSOD-mediated lifespan extension in Drosophila reveals a species-general network of aging and metabolic genes. Genome Biol (2007) 2.12
The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci (2008) 2.10
Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics (1996) 2.01
Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression. Genome Res (2005) 1.93
The C. elegans TGF-beta Dauer pathway regulates longevity via insulin signaling. Curr Biol (2007) 1.89
Insulin signaling promotes germline proliferation in C. elegans. Development (2010) 1.77
Dauer formation induced by high temperatures in Caenorhabditis elegans. Genetics (2000) 1.73
egl-4 acts through a transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to regulate multiple neuronal circuits in response to sensory cues. Genetics (2000) 1.71
Genetic and pharmacological factors that influence reproductive aging in nematodes. PLoS Genet (2006) 1.70
Testing an 'aging gene' in long-lived drosophila strains: increased longevity depends on sex and genetic background. Aging Cell (2003) 1.64
Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci U S A (1999) 1.62
Genetic and environmental conditions that increase longevity in Caenorhabditis elegans decrease metabolic rate. Proc Natl Acad Sci U S A (1999) 1.60
Comparative metabolomics reveals endogenous ligands of DAF-12, a nuclear hormone receptor, regulating C. elegans development and lifespan. Cell Metab (2014) 1.60
A novel nuclear receptor/coregulator complex controls C. elegans lipid metabolism, larval development, and aging. Genes Dev (2004) 1.57
The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci (2011) 1.55
Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure (2008) 1.55
TGF-beta Sma/Mab signaling mutations uncouple reproductive aging from somatic aging. PLoS Genet (2009) 1.54
The L-isoaspartyl-O-methyltransferase in Caenorhabditis elegans larval longevity and autophagy. Dev Biol (2006) 1.53
The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci U S A (1999) 1.52
Reproduction, fat metabolism, and life span: what is the connection? Cell Metab (2013) 1.51
Caenorhabditis elegans HCF-1 functions in longevity maintenance as a DAF-16 regulator. PLoS Biol (2008) 1.47
Insulin-like signaling and the neural circuit for integrative behavior in C. elegans. Genes Dev (2006) 1.46
Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci (2011) 1.44
Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease. J Inherit Metab Dis (2002) 1.43
Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philos Trans R Soc Lond B Biol Sci (2005) 1.41
Identification of C. elegans DAF-12-binding sites, response elements, and target genes. Genes Dev (2004) 1.39
Clustering of genetically defined allele classes in the Caenorhabditis elegans DAF-2 insulin/IGF-1 receptor. Genetics (2008) 1.38
Apoptosis maintains oocyte quality in aging Caenorhabditis elegans females. PLoS Genet (2008) 1.38
Neurosecretory control of aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1999) 1.37
The DAF-2 insulin-like signaling pathway independently regulates aging and immunity in C. elegans. Aging Cell (2008) 1.37
Positive selection of Caenorhabditis elegans mutants with increased stress resistance and longevity. Genetics (2003) 1.37
A metabolic signature of long life in Caenorhabditis elegans. BMC Biol (2010) 1.36
Ascaroside signaling in C. elegans. WormBook (2013) 1.35
Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J Gerontol A Biol Sci Med Sci (2004) 1.35
Genome-wide dFOXO targets and topology of the transcriptomic response to stress and insulin signalling. Mol Syst Biol (2011) 1.32
Modulation of lipid biosynthesis contributes to stress resistance and longevity of C. elegans mutants. Aging (Albany NY) (2011) 1.29
Longevity and stress in Caenorhabditis elegans. Aging (Albany NY) (2011) 1.28
The 14-3-3 protein FTT-2 regulates DAF-16 in Caenorhabditis elegans. Dev Biol (2006) 1.27
A transcription elongation factor that links signals from the reproductive system to lifespan extension in Caenorhabditis elegans. PLoS Genet (2009) 1.27
Glyceraldehyde-3-phosphate dehydrogenase mediates anoxia response and survival in Caenorhabditis elegans. Genetics (2006) 1.25
Hormesis and aging in Caenorhabditis elegans. Exp Gerontol (2006) 1.25
Mapping quantitative trait loci affecting life history traits in the nematode Caenorhabditis elegans. Genetics (1996) 1.24
Insulin/IGF1 signaling inhibits age-dependent axon regeneration. Neuron (2014) 1.23
Specific insulin-like peptides encode sensory information to regulate distinct developmental processes. Development (2011) 1.22
Comparative genomics of gene expression in the parasitic and free-living nematodes Strongyloides stercoralis and Caenorhabditis elegans. Genome Res (2004) 1.20
FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment. Mol Endocrinol (2008) 1.17
Is there a role for new invertebrate models for aging research? J Gerontol A Biol Sci Med Sci (2009) 1.13
Genetics, life span, health span, and the aging process in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci (2012) 1.11
PDP-1 links the TGF-β and IIS pathways to regulate longevity, development, and metabolism. PLoS Genet (2011) 1.10
Organ-specific mediation of lifespan extension: more than a gut feeling? Ageing Res Rev (2012) 1.10
MicroRNAs and the genetic network in aging. J Mol Biol (2013) 1.10
Distinct activities of the germline and somatic reproductive tissues in the regulation of Caenorhabditis elegans' longevity. Genetics (2008) 1.09
A novel 3-hydroxysteroid dehydrogenase that regulates reproductive development and longevity. PLoS Biol (2012) 1.07
The Caenorhabditis elegans germ line regulates distinct signaling pathways to control lifespan and innate immunity. J Biol Chem (2009) 1.05
Pheromone sensing regulates Caenorhabditis elegans lifespan and stress resistance via the deacetylase SIR-2.1. Proc Natl Acad Sci U S A (2013) 1.04
The Caenorhabditis elegans Lifespan Machine. Nat Methods (2013) 1.03
Insulin receptor substrate chico acts with the transcription factor FOXO to extend Drosophila lifespan. Aging Cell (2011) 1.02
DAF-12 regulates a connected network of genes to ensure robust developmental decisions. PLoS Genet (2011) 1.02
Activated AKT/PKB signaling in C. elegans uncouples temporally distinct outputs of DAF-2/insulin-like signaling. BMC Dev Biol (2006) 1.01
Genetic dissection of late-life fertility in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci (2011) 1.01
In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med (2013) 0.99
TGF-β signaling in C. elegans. WormBook (2013) 0.99
Chronological aging in Saccharomyces cerevisiae. Subcell Biochem (2012) 0.98
Functional divergence of dafachronic acid pathways in the control of C. elegans development and lifespan. Dev Biol (2010) 0.98
ROP-1, an RNA quality-control pathway component, affects Caenorhabditis elegans dauer formation. Proc Natl Acad Sci U S A (2000) 0.98
Caenorhabditis elegans PI3K mutants reveal novel genes underlying exceptional stress resistance and lifespan. Aging Cell (2009) 0.98
A search for doxycycline-dependent mutations that increase Drosophila melanogaster life span identifies the VhaSFD, Sugar baby, filamin, fwd and Cctl genes. Genome Biol (2003) 0.98
Regulation of gene expression is linked to life span in adult Drosophila. Genetics (1995) 0.97
DAF-16/Forkhead box O transcription factor: many paths to a single Fork(head) in the road. Antioxid Redox Signal (2010) 0.97
A Caenorhabditis elegans developmental decision requires insulin signaling-mediated neuron-intestine communication. Development (2014) 0.96
Caenorhabditis elegans battling starvation stress: low levels of ethanol prolong lifespan in L1 larvae. PLoS One (2012) 0.95
Reproductive aging in invertebrate genetic models. Ann N Y Acad Sci (2010) 0.95
O-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans. Genetics (2011) 0.95
Positive feedback between transcriptional and kinase suppression in nematodes with extraordinary longevity and stress resistance. PLoS Genet (2009) 0.95
C. elegans in high-throughput drug discovery. Adv Drug Deliv Rev (2013) 0.93
Genome-Wide RNAi Longevity Screens in Caenorhabditis elegans. Curr Genomics (2012) 0.93
Spindle assembly checkpoint gene mdf-1 regulates germ cell proliferation in response to nutrition signals in C. elegans. EMBO J (2008) 0.92
Reduction in ovulation or male sex phenotype increases long-term anoxia survival in a daf-16-independent manner in Caenorhabditis elegans. Physiol Genomics (2008) 0.92
TEP1, the yeast homolog of the human tumor suppressor gene PTEN/MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation. Proc Natl Acad Sci U S A (2000) 0.91
A uniform genetic nomenclature for the nematode Caenorhabditis elegans. Mol Gen Genet (1979) 10.47
Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics (1983) 7.54
The dauerlarva, a post-embryonic developmental variant of the nematode Caenorhabditis elegans. Dev Biol (1975) 7.20
A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics (1988) 5.60
Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature (1990) 5.23
Interacting genes in nematode dauer larva formation. Nature (1981) 5.21
Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech Ageing Dev (1978) 5.03
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell (1992) 4.68
daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics (1994) 4.32
Evidence for parallel processing of sensory information controlling dauer formation in Caenorhabditis elegans. Genetics (1993) 3.99
Aging and resistance to oxidative damage in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1993) 3.97
Specific neuroanatomical changes in chemosensory mutants of the nematode Caenorhabditis elegans. J Comp Neurol (1977) 3.53
The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature (1993) 3.45
Sensory control of dauer larva formation in Caenorhabditis elegans. J Comp Neurol (1981) 3.41
A pheromone-induced developmental switch in Caenorhabditis elegans: Temperature-sensitive mutants reveal a wild-type temperature-dependent process. Proc Natl Acad Sci U S A (1984) 3.39
Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell (1991) 3.28
daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell (1990) 3.16
Non-ageing developmental variant of Caenorhabditis elegans. Nature (1976) 3.09
More is not better: brood size and population growth in a self-fertilizing nematode. Proc Biol Sci (1991) 3.09
Critical periods in the development of the Caenorhabditis elegans dauer larva. Dev Biol (1981) 2.51
Oxidative stress and ageing in Caenorhabditis elegans. Biochem J (1993) 2.45
A gene affecting production of the Caenorhabditis elegans dauer-inducing pheromone. Mol Gen Genet (1985) 2.17
Mutants of Caenorhabditis elegans that form dauer-like larvae. Dev Biol (1988) 2.04
Developmental regulation of energy metabolism in Caenorhabditis elegans. Dev Biol (1989) 1.67
Developmental alterations in sensory neuroanatomy of the Caenorhabditis elegans dauer larva. J Comp Neurol (1983) 1.55
Quantitative genetics of postponed aging in Drosophila melanogaster. I. Analysis of outbred populations. Genetics (1991) 1.23
Intercellular signaling and signal transduction in C. elegans. Annu Rev Genet (1993) 1.13
The life cycle of the nematode Caenorhabditis elegans. II. A simplified method for mutant characterization. Dev Biol (1976) 0.91
Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90
Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics (1998) 5.37
The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther (1999) 5.31
Interacting genes in nematode dauer larva formation. Nature (1981) 5.21
The Caenorhabditis elegans dauer larva: developmental effects of pheromone, food, and temperature. Dev Biol (1984) 4.62
Control of C. elegans larval development by neuronal expression of a TGF-beta homolog. Science (1996) 4.23
A pheromone influences larval development in the nematode Caenorhabditis elegans. Science (1982) 3.88
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem (1994) 3.49
The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature (1993) 3.45
Sensory control of dauer larva formation in Caenorhabditis elegans. J Comp Neurol (1981) 3.41
A pheromone-induced developmental switch in Caenorhabditis elegans: Temperature-sensitive mutants reveal a wild-type temperature-dependent process. Proc Natl Acad Sci U S A (1984) 3.39
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell (1990) 3.16
Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA (2000) 3.13
daf-12 encodes a nuclear receptor that regulates the dauer diapause and developmental age in C. elegans. Genes Dev (2000) 3.03
Changes in gene expression associated with developmental arrest and longevity in Caenorhabditis elegans. Genome Res (2001) 2.96
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Frameshift suppression: a nucleotide addition in the anticodon of a glycine transfer RNA. Nat New Biol (1973) 2.67
Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics (1995) 2.54
Critical periods in the development of the Caenorhabditis elegans dauer larva. Dev Biol (1981) 2.51
Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst (2001) 2.43
Genetic, behavioral and environmental determinants of male longevity in Caenorhabditis elegans. Genetics (2000) 2.41
Longevity in Caenorhabditis elegans reduced by mating but not gamete production. Nature (1996) 2.38
Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther (1998) 2.35
Frameshift suppressors. 3. Effects of suppressor mutations on transfer RNA. J Mol Biol (1972) 2.33
A gene affecting production of the Caenorhabditis elegans dauer-inducing pheromone. Mol Gen Genet (1985) 2.17
dpy-13: a nematode collagen gene that affects body shape. Cell (1988) 2.05
Mutants of Caenorhabditis elegans that form dauer-like larvae. Dev Biol (1988) 2.04
Reliability of goniometric measurements and visual estimates of knee range of motion obtained in a clinical setting. Phys Ther (1991) 2.03
Goniometric reliability in a clinical setting. Shoulder measurements. Phys Ther (1987) 2.02
Health status measures: strategies and analytic methods for assessing change scores. Phys Ther (1996) 2.00
Suppressors of frameshift mutations in Salmonella typhimurium. J Mol Biol (1970) 1.93
A Caenorhabditis elegans RNA polymerase II gene, ama-1 IV, and nearby essential genes. Genetics (1988) 1.80
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
Indirect suppression in Caenorhabditis elegans. Genetics (1978) 1.74
Using published evidence to guide the examination of the sacroiliac joint region. Phys Ther (2001) 1.68
Developmental regulation of energy metabolism in Caenorhabditis elegans. Dev Biol (1989) 1.67
Fine structure of the Caenorhabditis elegans secretory-excretory system. J Ultrastruct Res (1983) 1.67
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol (1996) 1.64
Functional study of the Caenorhabditis elegans secretory-excretory system using laser microsurgery. J Exp Zool (1984) 1.64
Intertester reliability of judgments of the presence of trigger points in patients with low back pain. Arch Phys Med Rehabil (1992) 1.63
Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst (2001) 1.62
Intertester reliability of a modified version of McKenzie's lateral shift assessments obtained on patients with low back pain. Phys Ther (1996) 1.58
Developmental alterations in sensory neuroanatomy of the Caenorhabditis elegans dauer larva. J Comp Neurol (1983) 1.55
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
The shoulder pain and disability index: the construct validity and responsiveness of a region-specific disability measure. Phys Ther (1997) 1.48
RNA polymerase II from wild type and alpha-amanitin-resistant strains of Caenorhabditis elegans. J Biol Chem (1983) 1.44
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors. J Natl Cancer Inst (2001) 1.43
Intertester reliability of clinical judgments of medial knee ligament integrity. Phys Ther (1989) 1.43
LG II balancer chromosomes in Caenorhabditis elegans: mT1(II;III) and the mIn1 set of dominantly and recessively marked inversions. Mol Genet Genomics (2001) 1.39
Defining wild-type life span in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci (2000) 1.38
Frameshift suppressors. II. Genetic mapping and dominance studies. J Mol Biol (1972) 1.36
Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol (1995) 1.34
The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol (1995) 1.27
Molecular cloning and sequencing of ama-1, the gene encoding the largest subunit of Caenorhabditis elegans RNA polymerase II. Mol Cell Biol (1989) 1.27
A Caenorhabditis elegans type I TGF beta receptor can function in the absence of type II kinase to promote larval development. Development (2000) 1.25
Validity of derived measurements of leg-length differences obtained by use of a tape measure. Phys Ther (1990) 1.24
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
ACaenorhabditis elegans dauer-inducing pheromone and an antagonistic component of the food supply. J Chem Ecol (1984) 1.19
Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psychiatry Res (1996) 1.19
Reliability and validity of judgments of the integrity of the anterior cruciate ligament of the knee using the Lachman's test. Phys Ther (1990) 1.17
The nucleotide sequence of the GGG-specific glycine transfer ribonucleic acid of Escherichia coli and of Salmonella typhimurium. J Biol Chem (1973) 1.17
Mutant Caenorhabditis elegans RNA polymerase II with a 20,000-fold reduced sensitivity to alpha-amanitin. Genetics (1990) 1.13
Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology (1995) 1.12
Methods for taking subtalar joint measurements. A clinical report. Phys Ther (1988) 1.11
Laparoscopic ureterolithotomy. Urology (1992) 1.11
Fine-structure genetics of ama-1, an essential gene encoding the amanitin-binding subunit of RNA polymerase II in Caenorhabditis elegans. Genetics (1988) 1.10
Development and initial validation of the back pain functional scale. Spine (Phila Pa 1976) (2000) 1.09
Seizure frequency in intractable partial epilepsy: a statistical analysis. Epilepsia (1991) 1.09
Sensitive fluorescence in situ hybridization signal detection in maize using directly labeled probes produced by high concentration DNA polymerase nick translation. Biotech Histochem (2006) 1.08
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure. Neurology (1997) 1.08
Genetic balancers. Methods Cell Biol (1995) 1.06
Plant and soil nematodes: societal impact and focus for the future. J Nematol (1994) 1.05
Lethal and amanitin-resistance mutations in the Caenorhabditis elegans ama-1 and ama-2 genes. Genetics (1988) 1.05
Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol (2007) 1.04
Reliability of clinical measurements of forward bending using the modified fingertip-to-floor method. Phys Ther (1990) 1.00
Repeated probit regression when covariates are measured with error. Biometrics (1999) 0.99
Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. Eur J Clin Nutr (2005) 0.97
Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. Cancer Causes Control (2001) 0.97
Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues. Stat Med (2001) 0.97
An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma. Prostate Cancer Prostatic Dis (2006) 0.95
Efficacy of the Stone Cone for treatment of proximal ureteral stones. J Endourol (2004) 0.95
Acidic intracellular pH shift during Caenorhabditis elegans larval development. Proc Natl Acad Sci U S A (1988) 0.92
Adiposity and sex hormones across the menstrual cycle: the BioCycle Study. Int J Obes (Lond) (2012) 0.91
Leiomyoma of the tunica albuginea. J Urol (1972) 0.91
Differences in risk factors for incident and recurrent small-for-gestational-age birthweight: a hospital-based cohort study. BJOG (2014) 0.89
Retroperitoneal leiomyoma presenting as prostatic mass. Urology (1974) 0.89
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol (2001) 0.88
Environmental induction and genetic control of surface antigen switching in the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (1996) 0.87
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev (2003) 0.87